| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,185 |
2,723 |
$96K |
| L3000 |
Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each |
755 |
360 |
$94K |
| 73630 |
|
2,874 |
2,025 |
$46K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,988 |
1,189 |
$40K |
| 11721 |
|
1,790 |
1,621 |
$27K |
| L3030 |
Foot, insert, removable, formed to patient foot, each |
402 |
184 |
$26K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
580 |
534 |
$25K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
474 |
399 |
$19K |
| 11043 |
|
120 |
55 |
$6K |
| 73610 |
|
263 |
201 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
13 |
$963.27 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
47 |
40 |
$840.53 |
| 97760 |
|
27 |
27 |
$815.19 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
34 |
25 |
$39.25 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
34 |
25 |
$4.40 |